VA
TIL icon

VR Adviser’s Instil Bio TIL Stock Holding History

VR Adviser’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,177
Closed -$576K – 38
2025
Q1 		$576K Hold
33,177
– – 0.05% 37
2024
Q4 		$633K Hold
33,177
– – 0.04% 37
2024
Q3 		$2.23M Buy
+33,177
New +$781K 0.12% 37
2022
Q4 		– Sell
-205,289
Closed -$19.9M – 34
2022
Q3 		$19.9M Sell
205,289
-94,594
-32% -$10.8M 3.07% 13
2022
Q2 		$27.7M Sell
299,883
-43,371
-13% -$6.14M 5.46% 7
2022
Q1 		$73.8M Hold
343,254
– – 11.96% 2
2021
Q4 		$117M Hold
343,254
– – 16.06% 1
2021
Q3 		$123M Hold
343,254
– – 15.76% 1
2021
Q2 		$133M Hold
343,254
– – 16.09% 1
2021
Q1 		$172M Buy
+343,254
New +$176M 18.68% 1

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VR Adviser's TIL Position: Q2 2025 in Review

VR Adviser sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 33,177 shares — an estimated $576K sold.

VR Adviser first reported a position in TIL in Q1 2021 and held it in 10 quarters. The position peaked at $172M in Q1 2021. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

  • VR Adviser reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
  • VR Adviser sold 33,177 Instil Bio shares in Q2 2025, an estimated $576K.
  • VR Adviser first reported a position in Instil Bio in Q1 2021 and held it in 10 quarters.
  • VR Adviser's Instil Bio position peaked at $172M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on VR Adviser's 13F filing for Q2 2025, filed 14 Aug 2025.